Biotech Strategy Blog
Commentary on Science, Innovation & New Products with a focus on Oncology, Hematology & Immunotherapy
-
More than numbers
-
In a nutshell
-
Upping the Game
-
Beyond the antibody hype: small molecules show mixed results at ASCO25
-
Wired for Impact
-
Gunfight at the ASCO Corral
-
Breaking Barriers: ADCs cross into the brain as ASCO25 delivers surprises and disappointments
-
Finding the sweetspot
-
The Subtle Art of Bispecific Architecture
-
T Cell Engager Comeback: Why solid tumors may finally yield
-
Analysis of Pfizer’s Licensing Deal with 3SBio for SSGJ-707
-
10 lessons learned from Dr Sherene Loi at ESMO Breast
-
There’s always something coming on the inside rail
-
Red and green flags for CytomX’s CX-2051 in CRC
-
Promising Novel Targets or More of the Same?
-
The Therapeutic Index Dilemma
-
20 key lessons learned from AstraZeneca at AACR